Aurinia Pharmaceuticals Inc vs. Johnson & Johnson
Johnson & Johnson (JNJ) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| AUPH | JNJ | |
|---|---|---|
| Market Cap | $2.06 billion | $628.65 billion |
| Revenue (TTM) | $311.51 million | $97.93 billion |
| Net Income (TTM) | $314.11 million | $21.04 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| AUPH | JNJ | |
|---|---|---|
| P/E Ratio | 6.76 | 30.20 |
| Price / Book | 3.34 | 7.40 |
| Price / Sales | 6.60 | 6.42 |
AUPH leads on 2 of 3 valuation factors.
Profitability
| AUPH | JNJ | |
|---|---|---|
| Net Margin | 100.84% | 21.48% |
| Return on Equity | 51.09% | 24.76% |
AUPH leads on 2 of 2 profitability factors.
Dividend
| AUPH | JNJ | |
|---|---|---|
| Dividend Yield | — | 2.06% |
| Payout Ratio | — | 62.18 |
AUPH and JNJ split the dividend factors evenly.
Risk & Sentiment
| AUPH | JNJ | |
|---|---|---|
| Short Interest | 7.43% | 0.67% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: AUPH overview, AUPH financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.